Research advances of preoperative clinical prognostic factors for recurrent hepatocellular carcinoma after liver transplantation
10.3760/cma.j.cn421203-20221025-00276
- VernacularTitle:肝细胞癌肝移植后肿瘤复发的术前临床预测指标研究进展
- Author:
Yi BI
1
;
Yabei HUANG
;
Wentao JIANG
Author Information
1. 天津医科大学一中心临床学院，天津 300192
- Keywords:
Hepatocellular carcinoma;
Liver transplantation;
Recurrence;
Prognostic factors;
Prognoses
- From:
Chinese Journal of Organ Transplantation
2023;44(6):370-376
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation (LT) is an important treatment of unresectable hepatocellular carcinoma (HCC). However, the prognosis of tumor recurrence remains poor.If patients with a high risk of tumor recurrence after LT can be predicted preoperatively, suitable recipients are screened so that individualized monitoring and treatment protocols may be formulated for high-risk patients.Then better outcomes are obtained.Therefore it is imperative to accurately identify the relevant risk factors and select appropriate parameters for evaluate the risks of tumor recurrence before LT.This review summarized the latest researches of preoperative clinical predictors for recurrent HCC after LT.It was intended to provide references for selecting recipients and a proper management of high-risk patients.
